Inborn Gene or Chromosome Alterations Diagnostic Tests – Medical Devices Pipeline Assessment, 2017

“The Report Inborn Gene or Chromosome Alterations Diagnostic Tests – Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”

About Inborn Gene or Chromosome Alterations Diagnostic Tests Market

GlobalData’s Medical Devices sector report, Inborn Gene or Chromosome Alterations Diagnostic Tests – Medical Devices Pipeline Assessment, 2017″ provides an overview of Inborn Gene or Chromosome Alterations Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Inborn Gene or Chromosome Alterations Diagnostic Tests pipeline products.

Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1339330

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Inborn Gene or Chromosome Alterations Diagnostic Tests under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Inborn Gene or Chromosome Alterations Diagnostic Tests and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

View Report @ https://www.marketresearchreports.biz/reports/1339330/inborn-gene-or-chromosome-alterations-diagnostic-tests-medical-devices-pipeline-assessment-2017-market-research-reports

Reasons to buy

The report enables you to –

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Inborn Gene or Chromosome Alterations Diagnostic Tests under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the products current stage of development, territory and estimated launch date

Send An Enquiry Request @ https://www.marketresearchreports.biz/sample/enquiry/1339330

Table of Contents

1 Table of Contents 2

1.1 List of Tables 9

1.2 List of Figures 20

2 Introduction 21

2.1 Inborn Gene or Chromosome Alterations Diagnostic Tests Overview 21

3 Products under Development 22

3.1 Inborn Gene or Chromosome Alterations Diagnostic Tests – Pipeline Products by Stage of Development 22

3.2 Inborn Gene or Chromosome Alterations Diagnostic Tests – Pipeline Products by Territory 23

3.3 Inborn Gene or Chromosome Alterations Diagnostic Tests – Pipeline Products by Regulatory Path 24

3.4 Inborn Gene or Chromosome Alterations Diagnostic Tests – Pipeline Products by Estimated Approval Date 25

3.5 Inborn Gene or Chromosome Alterations Diagnostic Tests – Ongoing Clinical Trials 26

4 Inborn Gene or Chromosome Alterations Diagnostic Tests – Pipeline Products under Development by Companies 27

4.1 Inborn Gene or Chromosome Alterations Diagnostic Tests Companies – Pipeline Products by Stage of Development 27

4.2 Inborn Gene or Chromosome Alterations Diagnostic Tests – Pipeline Products by Stage of Development 32

5 Inborn Gene or Chromosome Alterations Diagnostic Tests Companies and Product Overview 39

5.1 3D Signatures Inc Company Overview 39

5.2 AbaStar MDx Inc Company Overview 40

5.3 Abital Pharma Pipelines Ltd Company Overview 43

5.4 Agena Bioscience, Inc Company Overview 44

5.5 AIT Austrian Institute of Technology GmbH Company Overview 45

5.6 Alexion Pharmaceuticals Inc Company Overview 46

5.7 Amarantus Bioscience Holdings Inc Company Overview 47

5.8 Amity University Company Overview 48

5.9 Ariosa Diagnostics Inc Company Overview 49

5.10 Arrayit Diagnostics, Inc. Company Overview 50

5.11 Asuragen Inc Company Overview 51

5.12 Augusta University Company Overview 52

5.13 AutoGenomics Inc Company Overview 53

5.14 Avellino Lab USA Inc Company Overview 63

5.15 Baylor College of Medicine Company Overview 64

5.16 BCML GmbH Company Overview 65

5.17 BioCeps (Inactive) Company Overview 66

5.18 Biocept Inc Company Overview 67

5.19 Celula Inc Company Overview 68

5.20 Center for Biomedical Research in Network of Rare Diseases Company Overview 69

5.21 Children’s Hospital Boston Company Overview 70

5.22 China Medical Technologies Inc (Inactive) Company Overview 72

5.23 ChipCare Corp Company Overview 73

5.24 Chronix Biomedical Inc Company Overview 74

5.25 Cincinnati Children’s Hospital Medical Center Company Overview 75

5.26 Columbia University Company Overview 80

5.27 Da An Gene Co Ltd Company Overview 82

5.28 Decipher GenX, Inc. Company Overview 84

5.29 D-Kimia, LLC. Company Overview 87

5.30 Duke University Company Overview 89

5.31 DxTerity Diagnostics Inc Company Overview 90

5.32 ELITechGroup Inc Company Overview 91

5.33 Epinex Diagnostics Inc Company Overview 92

5.34 Eppendorf AG Company Overview 93

5.35 Fina Biotech SL Company Overview 94

5.36 Firalis SAS Company Overview 95

5.37 Fluidigm Corp Company Overview 96

5.38 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV Company Overview 97

5.39 French National Institute of Health and Medical Research Company Overview 98

5.40 Genekam Biotechnology AG Company Overview 101

5.41 Genentech Inc Company Overview 102

5.42 Genetic Analysis AS Company Overview 103

5.43 GENEWIZ Inc Company Overview 105

5.44 German Cancer Research Center Company Overview 106

5.45 German Institute of Human Nutrition Company Overview 109

5.46 GILUPI Nanomedizin Company Overview 110

5.47 Good Start Genetics Inc Company Overview 111

5.48 Goodgene Inc Company Overview 113

5.49 Hadassah Medical Center Company Overview 114

5.50 Helicos BioSciences Corporation Company Overview 115

5.51 Helmholtz Center for Health and the Environment Munich Company Overview 116

5.52 Illumina, Inc. Company Overview 118

5.53 Immunexpress Pty Ltd Company Overview 121

5.54 Inform Genomics Inc Company Overview 124

5.55 Interleukin Genetics Inc Company Overview 126

5.56 International Biomedical Company Overview 127

5.57 Interpace Diagnostics, LLC Company Overview 128

5.58 John Hopkins University Company Overview 130

5.59 JS Genetics Inc Company Overview 133

5.60 Juneau Biosciences LLC Company Overview 134

5.61 KellBenx Inc Company Overview 136

5.62 Laboratory Corp of America Holdings Company Overview 138

5.63 Laval University Company Overview 139

5.64 LifeCodexx AG Company Overview 140

5.65 LineaGen Inc Company Overview 141

5.66 Maastricht University Medical Center Company Overview 142

5.67 Massachusetts Eye and Ear Infirmary Company Overview 143

5.68 Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Company Overview 145

5.69 Medical Research Council Company Overview 146

5.70 Multiplicom NV Company Overview 147

5.71 Nanosphere Inc Company Overview 148

5.72 National Institute of Immunohaematology Company Overview 150

5.73 National University of Singapore Company Overview 151

5.74 NewGene Ltd Company Overview 153

5.75 Northwestern University Company Overview 156

5.76 NX PharmaGen Inc Company Overview 157

5.77 OncoGenesis Company Overview 158

5.78 Oxford Biodynamics Plc Company Overview 159

5.79 Oxford Gene Technology Ltd Company Overview 175

5.80 Paragon Medical Inc Company Overview 176

5.81 Population Bio Inc Company Overview 177

5.82 PreCyte, Inc. Company Overview 188

5.83 Predictive Therapeutics LLC Company Overview 189

5.84 Premaitha Health Plc Company Overview 192

5.85 Prenetics Inc Company Overview 194

5.86 Prognomix Inc Company Overview 195

5.87 Proove BioScience Inc Company Overview 197

5.88 Quest Diagnostics Inc Company Overview 200

5.89 R-Biopharm AG Company Overview 205

5.90 Sansure Biotech Inc Company Overview 206

5.91 Sapien Biosciences Company Overview 207

5.92 Seattle Children’s Hospital Company Overview 209

5.93 Sequenom Inc Company Overview 210

5.94 Sequoia Genetics Company Overview 212

5.95 Sheba Medical Center Company Overview 213

5.96 SkylineDx BV Company Overview 214

5.97 Spartan Bioscience Inc Company Overview 215

5.98 Strand Life Sciences Pvt Ltd Company Overview 216

5.99 SUNY Upstate Medical University Company Overview 218

5.100 TAmiRNA GmbH Company Overview 219

5.101 TBG Diagnostics Ltd Company Overview 220

Buy Now @ https://www.researchmoz.com/checkout?rep_id=1339330&licType=S

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: sales@marketresearchreports.biz

Leave a Reply